<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38186472</PMID><DateRevised><Year>2024</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Long COVID-19 Syndrome: Insights From a Major Tertiary Center in the UK on Who Is at Greater Risk.</ArticleTitle><Pagination><StartPage>e50027</StartPage><MedlinePgn>e50027</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e50027</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.50027</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The COVID-19 pandemic triggered the unprecedented 'long COVID' crisis, with persistent symptoms beyond two months post-infection. This study explores the nexus between long COVID symptoms, patient demographics such as age, gender, and smoking, and clinical factors like vaccination, disease severity, and comorbidities.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective analysis of records was conducted between September 2021 and December 2022. The analysis covered adults with confirmed COVID-19 diagnoses. Data encompassed demographics, medical history, vaccination, disease severity, hospitalization, treatments, and post-COVID symptoms, analyzed using logistic regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 289 participants, the average age was 51.51 years. Around 62.6% were females, and 93% received the COVID-19 vaccination, i.e., primarily the mRNA vaccine (48.4%) and the adenovirus vector-based vaccine (34.8%). Reinfections occurred in 11.76% of cases. Disease severity varied, with 75% having mild, 15% having moderate, and 10% having severe infections. Hospitalization rates were significant (25.6%), including 10.7% requiring intensive care. Thirteen distinct post-COVID symptoms were reported. Fatigue, shortness of breath upon exertion, and brain fog emerged as the most prevalent symptoms. Notably, females exhibited higher symptom prevalence. Significant correlations were established between higher BMI and smoking with augmented symptomatology. Conversely, a link between booster doses and symptom reduction was discerned. Using multinomial regression analysis, gender and smoking were identified as predictors of post-COVID-19 symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The study underscores obesity, smoking, and the female gender's impact on long COVID symptoms; boosters show promise in alleviation. Respiratory pathology might underlie persistent symptoms in cases with radiological abnormalities and abnormal spirometry. Findings contribute to risk stratification, intervention strategies, and further research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Tariq Khan et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tariq Khan</LastName><ForeName>Saad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medicine, Darlington Memorial Hospital, Darlington, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rashid</LastName><ForeName>Khalid</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>General Internal Medicine, James Cook University Hospital, Middlesbrough, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ansar</LastName><ForeName>Farrukh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Medicine, Northwest School of Medicine, Khyber Medical University, Peshawar, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Muhammad Y</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Medical Education, Pak International Medical College, Peshawar, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali Khan</LastName><ForeName>Fahd</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Medicine, James Cook University Hospital, Middlesbrough, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebrahim Husain Ahmed Ali Ismaeel</LastName><ForeName>Rawan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medicine, James Cook University Hospital, Middlesbrough, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanif Mohammed</LastName><ForeName>Raheem</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medicine, James Cook University Hospital, Middlesbrough, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustafa</LastName><ForeName>Rehan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medicine, James Cook University Hospital, Middlesbrough, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tariq Khan</LastName><ForeName>Bisma</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medicine, Shaukat Khanum Memorial Hospital and Research Centre, Lahore, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tariq</LastName><ForeName>Behram</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medicine, James Cook University Hospital, Middlesbrough, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husssain</LastName><ForeName>Mubbashar</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medicine, James Cook University Hospital, Middlesbrough, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waheed</LastName><ForeName>Aamir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, Northampton General Hospital, Northampton, GBR.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">covid-19 vaccine</Keyword><Keyword MajorTopicYN="N">long covid-19</Keyword><Keyword MajorTopicYN="N">post-covid-19 symptoms</Keyword><Keyword MajorTopicYN="N">predictors of post covid-19 syndrome</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>4</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38186472</ArticleId><ArticleId IdType="pmc">PMC10767765</ArticleId><ArticleId IdType="doi">10.7759/cureus.50027</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>A new coronavirus associated with human respiratory disease in China. Wu F, Zhao S, Yu B, et al. Nature. 2020;579:265&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO declares COVID-19 a pandemic. Cucinotta D, Vanelli M. Acta Biomed. 2020;91:157&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard.  [
Nov;
2023 
]. 2023. https://covid19.who.int/ https://covid19.who.int/</Citation></Reference><Reference><Citation>Long COVID: current definition. Fern&#xe1;ndez-de-Las-Pe&#xf1;as C. Infection. 2022;50:285&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post COVID-19 condition by a Delphi consensus.  [
Nov;
2023 
];https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 2021 http://10http://00https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19, post-acute COVID-19 syndrome (PACS, "long COVID") and post-COVID-19 vaccination syndrome (PCVS, "post-COVIDvac-syndrome"): similarities and differences. Scholkmann F, May CA. Pathol Res Pract. 2023;246:154497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10154064</ArticleId><ArticleId IdType="pubmed">37192595</ArticleId></ArticleIdList></Reference><Reference><Citation>Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Martimbianco ALC, Pacheco RL, Bagattini &#xc2;M, Riera R. Int J Clin Pract. 2021;75:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: an overview. Raveendran AV, Jayadevan R, Sashidharan S. Diabetes Metab Syndr. 2021;15:869&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Huang C, Huang L, Wang Y, et al. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Unraveling the mystery surrounding post-acute sequelae of COVID-19. Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Front Immunol. 2021;12:686029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Persistent symptoms in patients after acute COVID-19. Carf&#xec; A, Bernabei R, Landi F. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Wu X, Liu X, Zhou Y, et al. Lancet Respir Med. 2021;9:747&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Alterations in T and B cell function persist in convalescent COVID-19 patients. Shuwa HA, Shaw TN, Knight SB, et al. Med. 2021;2:720&#x2013;735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="pubmed">33821250</ArticleId></ArticleIdList></Reference><Reference><Citation>Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. See&#xdf;le J, Waterboer T, Hippchen T, et al. Clin Infect Dis. 2022;74:1191&#x2013;1198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19) Ero&#x11f;lu &#x130;, Ero&#x11f;lu B&#xc7;, G&#xfc;ven GS. Nutrition. 2021;90:111308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8087860</ArticleId><ArticleId IdType="pubmed">34111831</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-acute sequelae of COVID-19: a metabolic perspective. Scherer PE, Kirwan JP, Rosen CJ. Elife. 2022;11:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8942467</ArticleId><ArticleId IdType="pubmed">35318939</ArticleId></ArticleIdList></Reference><Reference><Citation>The impact of post-COVID-syndrome on functioning &#x2014; results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany. Lemh&#xf6;fer C, Sturm C, Loudovici-Krug D, Best N, Gutenbrunner C. J Occup Med Toxicol. 2021;16:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8495185</ArticleId><ArticleId IdType="pubmed">34620202</ArticleId></ArticleIdList></Reference><Reference><Citation>Attributes and predictors of long COVID. Sudre CH, Murray B, Varsavsky T, et al. Nat Med. 2021;27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Arnold DT, Hamilton FW, Milne A, et al. Thorax. 2021;76:399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Townsend L, Dowds J, O'Brien K, et al. Ann Am Thorac Soc. 2021;18:997&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19) van den Borst B, Peters JB, Brink M, et al. Clin Infect Dis. 2021;73:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes and the risk of long-term post-COVID symptoms. Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Guijarro C, Torres-Macho J, Velasco-Arribas M, Plaza-Canteli S, Hern&#xe1;ndez-Barrera V, Arias-Naval&#xf3;n JA. Diabetes. 2021;70:2917&#x2013;2921.</Citation><ArticleIdList><ArticleId IdType="pubmed">34580087</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Munblit D, Bobkova P, Spiridonova E, et al. Clin Exp Allergy. 2021;51:1107&#x2013;1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Follow-up of adults with noncritical COVID-19 two months after symptom onset. Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Clin Microbiol Infect. 2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. J Infect Dis. 2022;226:1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Peckham H, de Gruijter NM, Raine C, et al. Nat Commun. 2020;11:6317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7726563</ArticleId><ArticleId IdType="pubmed">33298944</ArticleId></ArticleIdList></Reference><Reference><Citation>Age, sex and previous comorbidities as risk factors not associated with sars-cov-2 infection for long COVID-19: a systematic review and meta-analysis. Notarte KI, de Oliveira MH, Peligro PJ, et al. J Clin Med. 2022;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID-19 symptoms 6&#xa0;months after acute infection among hospitalized and non-hospitalized patients. Peghin M, Palese A, Venturini M, et al. Clin Microbiol Infect. 2021;27:1507&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Post&#x2011;COVID&#x2011;19 syndrome in outpatients: a cohort study. Desgranges F, Tadini E, Munting A, et al. J Gen Intern Med. 2022;37:1943&#x2013;1952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8939498</ArticleId><ArticleId IdType="pubmed">35319081</ArticleId></ArticleIdList></Reference><Reference><Citation>Understanding the impact of sociocultural gender. Gebhard CE, S&#xfc;tsch C, Bengs S, et al. medRxiv. 2021</Citation></Reference><Reference><Citation>Sex differences in immune responses. Klein SL, Flanagan KL. Nat Rev Immunol. 2016;16:626&#x2013;638.</Citation><ArticleIdList><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Thompson EJ, Williams DM, Walker AJ, et al. Nat Commun. 2022;13:3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Prognostic factors for post-COVID-19 syndrome: a systematic review and meta-analysis. Maglietta G, Diodati F, Puntoni M, Lazzarelli S, Marcomini B, Patrizi L, Caminiti C. J Clin Med. 2022;11:1541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>The effectiveness of coronavirus disease 2019 (COVID-19) vaccine in the prevention of post-COVID-19 conditions: a systematic literature review and meta-analysis. Marra AR, Kobayashi T, Suzuki H, et al. Antimicrob Steward Healthc Epidemiol. 2022;2:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9726631</ArticleId><ArticleId IdType="pubmed">36505947</ArticleId></ArticleIdList></Reference><Reference><Citation>Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Taquet M, Dercon Q, Harrison PJ. Brain Behav Immun. 2022;103:154&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. Zhao YM, Shang YM, Song WB, et al. EClinicalMedicine. 2020;25:100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>